Related Experiment Video
Updated: May 2, 2026

Identifying Microglia and Peripheral Infiltrating Macrophages in the Injured Spinal Cords Using Flow Cytometry
Published on: June 24, 2025
Spatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly
Jacob Kjell1, Simone Codeluppi, Anna Josephson
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Mechanistic target of rapamycin complex 1 (mTORC1) is an intracellular kinase complex that regulates energy homeostasis and transcription. Modulation of mTORC1 has proven beneficial in experimental spinal cord injury, making this molecular target a candidate for therapeutic intervention in spinal cord injury. However, both inactivation and activation of mTORC1 have been reported beneficial for recovery. To obtain a more complete picture of mTORC1 activity, we aimed to characterize the spatiotemporal activation pattern of mTORC1 and identify activation in particular cell types after contusion spinal cord injury in rats. To be able to provide a spatial characterization of mTORC1 activation, we monitored activation of downstream target S6. We found robust mTORC1 activation both at the site of injury and in spinal segments rostral and caudal to the injury. There was constitutive mTORC1 activation in neurons that was biphasically reduced caudally after injury. We found biphasic mTORC1 activation in glial cells, primarily activated microglia/macrophages. Furthermore, we found mTORC1 activation in proliferating cells, suggesting this may be a function affected by mTORC1 modulation. Our results reveal potential windows of opportunity for therapeutic interference with mTORC1 signaling and immune cells as targets for inhibition of mTORC1 in spinal cord injury.
Insights
Mechanistic target of rapamycin complex 1 (mTORC1) signaling is activated in neurons and glial cells after spinal cord injury. Understanding its spatiotemporal pattern offers therapeutic opportunities for spinal cord injury recovery.
Area of Science:
- Neuroscience
- Cellular Biology
- Biochemistry
Background:
- Mechanistic target of rapamycin complex 1 (mTORC1) is a key regulator of cellular processes.
- mTORC1 signaling plays a role in energy homeostasis and transcription.
- Modulating mTORC1 shows therapeutic potential in experimental spinal cord injury models.
Purpose of the Study:
- To characterize the spatiotemporal activation pattern of mTORC1 after contusion spinal cord injury.
- To identify specific cell types exhibiting mTORC1 activation post-injury.
- To reveal therapeutic windows for mTORC1 modulation in spinal cord injury.
Main Methods:
- Utilized a rat contusion spinal cord injury model.
- Monitored mTORC1 activation by assessing its downstream target, S6.
- Performed spatial and cell-type specific analysis of mTORC1 activity.
Main Results:
- Observed robust mTORC1 activation at the injury site and adjacent spinal segments.
- Found constitutive neuronal mTORC1 activation, biphasically reduced caudally.
- Detected biphasic mTORC1 activation in glial cells, particularly activated microglia/macrophages.
- Identified mTORC1 activation in proliferating cells post-injury.
Conclusions:
- mTORC1 activation exhibits complex spatiotemporal dynamics following spinal cord injury.
- Neurons and activated immune cells are key cell types with altered mTORC1 activity.
- Targeting mTORC1 in specific cell types and at defined time points may offer therapeutic benefits for spinal cord injury.
More Related Videos
13:28Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
08:43Intravital Imaging of Axonal Interactions with Microglia and Macrophages in a Mouse Dorsal Column Crush Injury
Published on: November 23, 2014
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Spinal Cord Injury ll: Pathophysiology
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Neurogenesis and Regeneration of Nervous Tissue